183 related articles for article (PubMed ID: 14769391)
1. Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord.
Lemons ML; Sandy JD; Anderson DK; Howland DR
Exp Neurol; 2003 Dec; 184(2):981-90. PubMed ID: 14769391
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of chondroitin sulfate proteoglycans from embryonic quail that influence neural crest cell behavior.
Kerr RS; Newgreen DF
Dev Biol; 1997 Dec; 192(1):108-24. PubMed ID: 9405101
[TBL] [Abstract][Full Text] [Related]
3. Effects of extracellular matrix components on axonal outgrowth from peripheral nerves of adult animals in vitro.
Tonge DA; Golding JP; Edbladh M; Kroon M; Ekström PE; Edström A
Exp Neurol; 1997 Jul; 146(1):81-90. PubMed ID: 9225741
[TBL] [Abstract][Full Text] [Related]
4. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.
Davies JE; Tang X; Denning JW; Archibald SJ; Davies SJ
Eur J Neurosci; 2004 Mar; 19(5):1226-42. PubMed ID: 15016081
[TBL] [Abstract][Full Text] [Related]
5. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection.
Tsai EC; Dalton PD; Shoichet MS; Tator CH
Biomaterials; 2006 Jan; 27(3):519-33. PubMed ID: 16099035
[TBL] [Abstract][Full Text] [Related]
6. On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system.
Asher RA; Scheibe RJ; Keiser HD; Bignami A
Glia; 1995 Apr; 13(4):294-308. PubMed ID: 7615338
[TBL] [Abstract][Full Text] [Related]
7. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars.
McKeon RJ; Höke A; Silver J
Exp Neurol; 1995 Nov; 136(1):32-43. PubMed ID: 7589332
[TBL] [Abstract][Full Text] [Related]
8. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.
Moon LD; Asher RA; Fawcett JW
J Neurosci Res; 2003 Jan; 71(1):23-37. PubMed ID: 12478611
[TBL] [Abstract][Full Text] [Related]
9. CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension.
Gilbert RJ; McKeon RJ; Darr A; Calabro A; Hascall VC; Bellamkonda RV
Mol Cell Neurosci; 2005 Aug; 29(4):545-58. PubMed ID: 15936953
[TBL] [Abstract][Full Text] [Related]
10. Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
Brain; 2007 Apr; 130(Pt 4):940-53. PubMed ID: 17314203
[TBL] [Abstract][Full Text] [Related]
11. Human intervertebral disc cells promote nerve growth over substrata of human intervertebral disc aggrecan.
Johnson WE; Sivan S; Wright KT; Eisenstein SM; Maroudas A; Roberts S
Spine (Phila Pa 1976); 2006 May; 31(11):1187-93. PubMed ID: 16688030
[TBL] [Abstract][Full Text] [Related]
12. Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.
Lemons ML; Sandy JD; Anderson DK; Howland DR
J Neurosci; 2001 Jul; 21(13):4772-81. PubMed ID: 11425904
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and proteoglycans in axonal regeneration.
Pizzi MA; Crowe MJ
Exp Neurol; 2007 Apr; 204(2):496-511. PubMed ID: 17254568
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 upregulates keratan sulfate and chondroitin sulfate biosynthesis in microglias after brain injury.
Yin J; Sakamoto K; Zhang H; Ito Z; Imagama S; Kishida S; Natori T; Sawada M; Matsuyama Y; Kadomatsu K
Brain Res; 2009 Mar; 1263():10-22. PubMed ID: 19368826
[TBL] [Abstract][Full Text] [Related]
15. [Axonal growth inhibition by chondroitin sulfate proteoglycans in the central nervous system].
Díaz-Martínez NE; Velasco I
Rev Invest Clin; 2009; 61(2):140-9. PubMed ID: 19637728
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia.
Properzi F; Carulli D; Asher RA; Muir E; Camargo LM; van Kuppevelt TH; ten Dam GB; Furukawa Y; Mikami T; Sugahara K; Toida T; Geller HM; Fawcett JW
Eur J Neurosci; 2005 Jan; 21(2):378-90. PubMed ID: 15673437
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic-based strip assay for testing the effects of various surface-bound inhibitors in spinal cord injury.
Vahidi B; Park JW; Kim HJ; Jeon NL
J Neurosci Methods; 2008 May; 170(2):188-96. PubMed ID: 18314199
[TBL] [Abstract][Full Text] [Related]
18. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.
Guerassimov A; Zhang Y; Banerjee S; Cartman A; Leroux JY; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR
Arthritis Rheum; 1998 Jun; 41(6):1019-25. PubMed ID: 9627011
[TBL] [Abstract][Full Text] [Related]
19. Human intervertebral disc aggrecan inhibits nerve growth in vitro.
Johnson WE; Caterson B; Eisenstein SM; Hynds DL; Snow DM; Roberts S
Arthritis Rheum; 2002 Oct; 46(10):2658-64. PubMed ID: 12384924
[TBL] [Abstract][Full Text] [Related]
20. Structure of chondroitin sulfate on aggrecan isolated from bovine tibial and costochondral growth plates.
Deutsch AJ; Midura RJ; Plaas AH
J Orthop Res; 1995 Mar; 13(2):230-9. PubMed ID: 7722760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
